AP-HM - Hôpital Nord

Marseille

0 studies enrolling now · 2 studies all time

What they study most

HER2 Exon 20 Mutation, Non-squamous NSCLC, Squamous NSCLC

Studies at this site

• Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) — Withdrawn before enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed